These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 21535997

  • 1. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression.
    Wirz-Justice A, Bader A, Frisch U, Stieglitz RD, Alder J, Bitzer J, Hösli I, Jazbec S, Benedetti F, Terman M, Wisner KL, Riecher-Rössler A.
    J Clin Psychiatry; 2011 Jul; 72(7):986-93. PubMed ID: 21535997
    [Abstract] [Full Text] [Related]

  • 2. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 3. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial.
    Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, Hoogendijk WJ.
    Arch Gen Psychiatry; 2011 Jan; 68(1):61-70. PubMed ID: 21199966
    [Abstract] [Full Text] [Related]

  • 4. Novel Augmentation Strategies in Major Depression.
    Martiny K.
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [Abstract] [Full Text] [Related]

  • 5. Bright light augments antidepressant effects of medication and wake therapy.
    Loving RT, Kripke DF, Shuchter SR.
    Depress Anxiety; 2002 Apr; 16(1):1-3. PubMed ID: 12203667
    [Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled 8-week trial of the efficacy and tolerability of multiple doses of Lu AA21004 in adults with major depressive disorder.
    Henigsberg N, Mahableshwarkar AR, Jacobsen P, Chen Y, Thase ME.
    J Clin Psychiatry; 2012 Jul; 73(7):953-9. PubMed ID: 22901346
    [Abstract] [Full Text] [Related]

  • 7. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury.
    Rapoport MJ, Mitchell RA, McCullagh S, Herrmann N, Chan F, Kiss A, Feinstein A, Lanctôt KL.
    J Clin Psychiatry; 2010 Sep; 71(9):1125-30. PubMed ID: 20441723
    [Abstract] [Full Text] [Related]

  • 9. Bright light therapy in pregnant women with major depressive disorder: study protocol for a randomized, double-blind, controlled clinical trial.
    Bais B, Kamperman AM, van der Zwaag MD, Dieleman GC, Harmsen van der Vliet-Torij HW, Bijma HH, Lieverse R, Hoogendijk WJ, Lambregtse-van den Berg MP.
    BMC Psychiatry; 2016 Nov 08; 16(1):381. PubMed ID: 27821114
    [Abstract] [Full Text] [Related]

  • 10. Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.
    Khajavi D, Farokhnia M, Modabbernia A, Ashrafi M, Abbasi SH, Tabrizi M, Akhondzadeh S.
    J Clin Psychiatry; 2012 Nov 08; 73(11):1428-33. PubMed ID: 23146150
    [Abstract] [Full Text] [Related]

  • 11. Supportive psychotherapy for perinatal depression: preliminary data for adherence and response.
    Freeman MP, Davis MF.
    Depress Anxiety; 2010 Nov 08; 27(1):39-45. PubMed ID: 19691033
    [Abstract] [Full Text] [Related]

  • 12. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R, da Silva Telles RM, Alves TC, Andrei AM, Rays J, Iosifescu DV, Wajngarten M.
    Contemp Clin Trials; 2009 May 08; 30(3):205-11. PubMed ID: 19470312
    [Abstract] [Full Text] [Related]

  • 13. A randomized, placebo-controlled trial of bright light and high-density negative air ions for treatment of Seasonal Affective Disorder.
    Flory R, Ametepe J, Bowers B.
    Psychiatry Res; 2010 May 15; 177(1-2):101-8. PubMed ID: 20381162
    [Abstract] [Full Text] [Related]

  • 14. Narrow-band blue-light treatment of seasonal affective disorder in adults and the influence of additional nonseasonal symptoms.
    Strong RE, Marchant BK, Reimherr FW, Williams E, Soni P, Mestas R.
    Depress Anxiety; 2009 May 15; 26(3):273-8. PubMed ID: 19016463
    [Abstract] [Full Text] [Related]

  • 15. Comparison of venlafaxine alone versus venlafaxine plus bright light therapy combination for severe major depressive disorder.
    Güzel Özdemir P, Boysan M, Smolensky MH, Selvi Y, Aydin A, Yilmaz E.
    J Clin Psychiatry; 2015 May 15; 76(5):e645-54. PubMed ID: 26035199
    [Abstract] [Full Text] [Related]

  • 16. Short-term efficacy and safety of desvenlafaxine in a randomized, placebo-controlled study of perimenopausal and postmenopausal women with major depressive disorder.
    Kornstein SG, Jiang Q, Reddy S, Musgnung JJ, Guico-Pabia CJ.
    J Clin Psychiatry; 2010 Aug 15; 71(8):1088-96. PubMed ID: 20797382
    [Abstract] [Full Text] [Related]

  • 17. A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.
    Martiny K, Refsgaard E, Lund V, Lunde M, Sørensen L, Thougaard B, Lindberg L, Bech P.
    J Clin Psychiatry; 2012 Sep 15; 73(9):1234-42. PubMed ID: 23059149
    [Abstract] [Full Text] [Related]

  • 18. A controlled trial of light therapy for the treatment of pediatric seasonal affective disorder.
    Swedo SE, Allen AJ, Glod CA, Clark CH, Teicher MH, Richter D, Hoffman C, Hamburger SD, Dow S, Brown C, Rosenthal NE.
    J Am Acad Child Adolesc Psychiatry; 1997 Jun 15; 36(6):816-21. PubMed ID: 9183137
    [Abstract] [Full Text] [Related]

  • 19. A controlled comparison of light box and head-mounted units in the treatment of seasonal depression.
    Levitt AJ, Wesson VA, Joffe RT, Maunder RG, King EF.
    J Clin Psychiatry; 1996 Mar 15; 57(3):105-10. PubMed ID: 8617693
    [Abstract] [Full Text] [Related]

  • 20. Assessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trials.
    Soares CN, Kornstein SG, Thase ME, Jiang Q, Guico-Pabia CJ.
    J Clin Psychiatry; 2009 Oct 15; 70(10):1365-71. PubMed ID: 19906341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.